PT2978416T - Formulação farmacêutica compreendendo fosfatidilcolina para o tratamento de colite ulcerosa - Google Patents

Formulação farmacêutica compreendendo fosfatidilcolina para o tratamento de colite ulcerosa

Info

Publication number
PT2978416T
PT2978416T PT147138085T PT14713808T PT2978416T PT 2978416 T PT2978416 T PT 2978416T PT 147138085 T PT147138085 T PT 147138085T PT 14713808 T PT14713808 T PT 14713808T PT 2978416 T PT2978416 T PT 2978416T
Authority
PT
Portugal
Prior art keywords
phosphatidylcholine
treatment
pharmaceutical formulation
ulcerative colitis
ulcerative
Prior art date
Application number
PT147138085T
Other languages
English (en)
Portuguese (pt)
Inventor
Keilhauer Gerhard
Original Assignee
Lipid Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipid Therapeutics Gmbh filed Critical Lipid Therapeutics Gmbh
Publication of PT2978416T publication Critical patent/PT2978416T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT147138085T 2013-03-26 2014-03-25 Formulação farmacêutica compreendendo fosfatidilcolina para o tratamento de colite ulcerosa PT2978416T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13161089 2013-03-26

Publications (1)

Publication Number Publication Date
PT2978416T true PT2978416T (pt) 2016-12-09

Family

ID=47913311

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147138085T PT2978416T (pt) 2013-03-26 2014-03-25 Formulação farmacêutica compreendendo fosfatidilcolina para o tratamento de colite ulcerosa

Country Status (26)

Country Link
US (1) US20160045523A1 (ja)
EP (1) EP2978416B1 (ja)
JP (1) JP6262843B2 (ja)
KR (1) KR20150132841A (ja)
CN (1) CN105377247B (ja)
AU (1) AU2014243102B2 (ja)
BR (1) BR112015023849A2 (ja)
CA (1) CA2907401A1 (ja)
CL (1) CL2015002832A1 (ja)
DK (1) DK2978416T3 (ja)
EA (1) EA029514B1 (ja)
ES (1) ES2605650T3 (ja)
HK (1) HK1217089A1 (ja)
HU (1) HUE030707T2 (ja)
IL (1) IL241019A0 (ja)
LT (1) LT2978416T (ja)
MD (1) MD20150089A2 (ja)
MX (1) MX2015013511A (ja)
PE (1) PE20160037A1 (ja)
PH (1) PH12015502199A1 (ja)
PL (1) PL2978416T3 (ja)
PT (1) PT2978416T (ja)
SG (1) SG11201507777TA (ja)
UA (1) UA115585C2 (ja)
WO (1) WO2014154683A1 (ja)
ZA (1) ZA201507910B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5715070B2 (ja) 2009-02-16 2015-05-07 ノグラ ファーマ リミテッド アルキルアミド化合物およびその使用
CN104254327A (zh) 2012-02-09 2014-12-31 诺格拉制药有限公司 治疗纤维化的方法
JP7125350B2 (ja) * 2016-02-26 2022-08-24 ノグラ ファーマ リミテッド ラクトース不耐性を処置する方法
CN113825739A (zh) 2019-02-08 2021-12-21 诺格拉制药有限公司 制备3-(4’-氨基苯基)-2-甲氧基丙酸及其类似物和中间体的方法
CA3132738A1 (en) * 2019-03-05 2020-09-10 Sichuan Gowell Pharmaceutical Co., Ltd. Fatty acid composition and application thereof
CN113368118B (zh) * 2021-07-21 2022-09-23 中国药科大学 磷脂酰胆碱在制备治疗溃疡性结肠炎的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3022136C2 (de) * 1980-06-13 1986-07-17 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zum Abfüllen von Phospholipide enthaltenden pharmazeutischen Massen in Hartkapseln
US4560655A (en) * 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
IT1243981B (it) * 1990-10-01 1994-06-28 Fidia Spa Composizioni per il trattamento della pelle contenenti derivati della b-fosfatidilcolina
US5453523A (en) * 1993-06-16 1995-09-26 Emulsion Technology, Inc. Process for obtaining highly purified phosphatidylcholine
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
JP2002522381A (ja) * 1998-08-06 2002-07-23 ストレンメル，ボルフガング 粘膜保護用医薬としてのホスファチジルコリン
WO2009015891A1 (en) * 2007-07-31 2009-02-05 Wolfgang Stremmel Use of phosphatidylcholine for treating steroid-dependent and steroid-refractory ulcerative colitis
CN102633832B (zh) * 2011-02-09 2015-07-22 北京绿色金可生物技术股份有限公司 一种制备高纯度磷脂酰胆碱的方法

Also Published As

Publication number Publication date
CN105377247B (zh) 2019-04-26
EP2978416B1 (en) 2016-10-26
PE20160037A1 (es) 2016-02-04
JP6262843B2 (ja) 2018-01-17
SG11201507777TA (en) 2015-10-29
AU2014243102A1 (en) 2015-09-17
ZA201507910B (en) 2017-04-26
IL241019A0 (en) 2015-11-30
DK2978416T3 (en) 2016-12-19
EA029514B1 (ru) 2018-04-30
PH12015502199A1 (en) 2016-01-25
CL2015002832A1 (es) 2016-03-11
CN105377247A (zh) 2016-03-02
ES2605650T3 (es) 2017-03-15
EA201591510A1 (ru) 2016-01-29
HK1217089A1 (zh) 2016-12-23
LT2978416T (lt) 2016-12-12
UA115585C2 (uk) 2017-11-27
EP2978416A1 (en) 2016-02-03
WO2014154683A1 (en) 2014-10-02
MX2015013511A (es) 2016-06-28
CA2907401A1 (en) 2014-10-02
HUE030707T2 (en) 2017-05-29
PL2978416T3 (pl) 2017-03-31
JP2016516087A (ja) 2016-06-02
MD20150089A2 (ro) 2016-03-31
AU2014243102B2 (en) 2018-04-26
US20160045523A1 (en) 2016-02-18
BR112015023849A2 (pt) 2017-07-18
KR20150132841A (ko) 2015-11-26

Similar Documents

Publication Publication Date Title
HK1217089A1 (zh) 用於治療潰瘍性結腸炎含磷脂酰胆碱的藥物製劑
HK1208378A1 (en) Pharmaceutical composition for the treatment of fungal infections
SI2812013T1 (sl) Formulacija za zdravljenje SRČ-ja
HK1245653A1 (zh) 藥物製劑
ZA201604225B (en) Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus
IL253177A0 (en) Pharmacy preparation
LT3052466T (lt) Ksantohumolio paruošimo būdas
EP2968195A4 (en) PHARMACEUTICAL FORMULATION WITH GLYCOSAMINOGLYCAN
EP3383371C0 (en) PHARMACEUTICAL FORMULATION
ZA201508452B (en) Oral formulation for the treatment of cardiovascular diseases
HK1204916A1 (en) Pharmaceutical application of anhydroicaritin
PT3340975T (pt) Formulação para o tratamento de acne
GB201511246D0 (en) Pharmaceutical formulation
EP2964257A4 (en) TRANSCUTANEOUS DOSE FORMULATION
HK1212587A1 (zh) 用於預防或者治療糖尿病的製劑
IL244316A0 (en) A new composition of a drug
GB201207476D0 (en) pharmaceutical for the treatment of leishmaniasis